ILLUMINA, INC.

ILMN
Delayed Quote. Delayed  - 08/04 04:00:00 pm
393.68USD -1.05%
Prev.397.8600
Open397.7300
High399.3100
Low391.0200
Volume1 033 008
Latest news
1d ago
07/16
07/08
06/23
Chart ILLUMINA, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance399399468
Spread/Res.-1,2%-1,2%-16%
Spread/Supp.3,8%29%29%
Support379306306
Financials
Sales 2020 3 492 M - -
Net income 2020 778 M - -
Net cash 2020 2 501 M - -
P/E ratio 2020 76,1x
Yield 2020 -
Capitalization 57 871 M 57 871 M -
EV / Sales 2020 15,9x
EV / Sales 2021 12,9x
Nbr of Employees 7 700
Free-Float 75,5%
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations,...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2020-08-06 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 341,06 $
Last Close Price 393,68 $
Spread / Highest target 1,61%
Spread / Average Target -13,4%
Spread / Lowest Target -44,1%